Revelation Biosciences, Inc. (REVB)

NASDAQ: REVB · IEX Real-Time Price · USD

1.790

-0.080 (-4.28%)

At close: Jul 2, 2024, 4:00 PM

1.761

-0.029 (-1.62%)

After-hours: Jul 2, 2024, 4:28 PM EDT

Revelation Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	11.99	5.25	1.27	4.49	0
Cash & Cash Equivalents	11.99	5.25	1.27	4.49	0
Cash Growth	128.28%	312.09%	-71.62%	-	-
Other Current Assets	0.16	0.16	0.64	0.13	0.02
Total Current Assets	12.15	5.41	1.91	4.62	0.02
Property, Plant & Equipment	0.07	0.09	0.13	0	0
Total Long-Term Assets	0.07	0.09	0.13	0	0
Total Assets	12.21	5.5	2.04	4.62	0.02
Accounts Payable	1.36	0.55	0.6	0.87	0.02
Current Debt	0	0	0.02	0	0.01
Other Current Liabilities	4.2	3.9	1.53	0.34	0
Total Current Liabilities	5.56	4.45	2.14	1.21	0.03
Total Liabilities	5.56	4.45	2.14	1.21	0.03
Total Debt	0	0	0.02	0	0.01
Retained Earnings	-25.47	-25.35	-14.52	-2.53	-0
Shareholders' Equity	6.65	1.05	-0.1	3.41	-0
Net Cash / Debt	11.99	5.25	1.26	4.49	-0.01
Net Cash / Debt Growth	128.28%	317.57%	-72.00%	-	-
Net Cash Per Share	52.45	72.37	133.81	1957.47	-
Working Capital	6.58	0.96	-0.23	3.41	-0
Book Value Per Share	29.07	14.50	-10.58	1486.42	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).